Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans.

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Moderau, Nina; Poyia, Fotini; Schwartzberg, Lee S; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Moderau, Nina; Poyia, Fotini; Schwartzberg, Lee S; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin.

Afiliación

Carter P; Department of Surgery and Cancer, Imperial College, London, UK.
Alifrangis C; Department of Oncology, University College Hospital, London, UK.
Cereser B; Department of Surgery and Cancer, Imperial College, London, UK.
Chandrasinghe P; Department of Surgery and Cancer, Imperial College, London, UK.
Del Bel Belluz L; Department of Surgery, University of Kelaniya, Kelaniya, Sri Lanka.
Moderau N; Department of Surgery and Cancer, Imperial College, London, UK.
Poyia F; Department of Surgery and Cancer, Imperial College, London, UK.
Schwartzberg LS; Department of Surgery and Cancer, Imperial College, London, UK.
Tabassum N; West Cancer Center, The University of Tennessee, Memphis, USA.
Wen J; Department of Surgery and Cancer, Imperial College, London, UK.
Krell J; Department of Surgery and Cancer, Imperial College, London, UK.
Stebbing J; Department of Surgery and Cancer, Imperial College, London, UK.

Oncotarget ; 9(25): 17589-17596, 2018 Apr 03.

Article en En | MEDLINE | ID: mdl-29707132

Palabras clave

breast cancer; cancer treatment; tumor profiling

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google